Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biodesix Inc (NQ: BDSX ) 1.710 +0.010 (+0.59%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biodesix Inc < Previous 1 2 3 4 5 6 7 Next > Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022 April 20, 2022 Upgrades Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session April 18, 2022 Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million. Via Benzinga The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More April 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Stocks That Hit 52-Week Lows On Friday March 25, 2022 On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Recap: Biodesix Q4 Earnings March 14, 2022 Biodesix (NASDAQ:BDSX) reported its Q4 earnings results on Monday, March 14, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga 68 Biggest Movers From Yesterday April 19, 2022 Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... Via Benzinga A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report April 12, 2022 Pre-open movers U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation... Via Benzinga Preview: Biodesix's Earnings March 11, 2022 Biodesix (NASDAQ:BDSX) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 12, 2022 Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday! Via InvestorPlace Why This Nano-Cap Healthcare Stock Spiked Over 80% After-Hours Today April 12, 2022 Shares of Biodesix, Inc. (NASDAQ: BDSX), a lung disease-focused diagnostics company, skyrocketed in after-hours trading on Monday. Via Benzinga Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan April 11, 2022 From Biodesix, Inc. Via Business Wire Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer March 29, 2022 From Biodesix, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Monday March 28, 2022 On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Stocks That Hit 52-Week Lows On Thursday March 24, 2022 On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market... Via Benzinga Biodesix's Return On Capital Employed Insights March 15, 2022 Biodesix (NASDAQ:BDSX) brought in sales totaling $7.22 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.36%, resulting in a loss of $13... Via Benzinga Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights March 14, 2022 From Biodesix Via Business Wire The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022 February 28, 2022 From Biodesix, Inc. Via Business Wire Earnings Scheduled For March 14, 2022 March 14, 2022 Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (... Via Benzinga Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022 February 22, 2022 From Biodesix, Inc. Via Business Wire 73 Biggest Movers From Yesterday February 23, 2022 Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE... Via Benzinga Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited) February 14, 2022 From Biodesix, Inc. Via Business Wire Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 09, 2022 From Biodesix, Inc. Via Business Wire 64 Biggest Movers From Yesterday February 01, 2022 Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a... Via Benzinga PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics January 19, 2022 From PierianDx Via Business Wire Biodesix Announces the Launch of its GeneStrat NGS™ Test and the IQLung™ Testing Strategy with Unprecedented Time to Results January 18, 2022 From Biodesix, Inc. Via Business Wire Insider Weekends: Co-Founder Of EverQuote Acquires $1.45 Million Worth Of Stock January 09, 2022 Reviewing the list of companies that were at a new 52 week high and the ones that had hit a fresh 52 week low last week, I was struck by just how many of the companies in the 52... Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets January 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... Via Benzinga Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan January 04, 2022 From Biodesix, Inc. Via Business Wire 40 Biggest Movers From Friday January 03, 2022 Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.